Form 7 Monthly Progress Report January 1 2023
Form 7 Monthly Progress Report February 1 2023 Name of Listed Issuer: Trading Symbol: Number of Outstanding Listed Securities: Date: BioMark Diagnostics Inc. (the “Issuer”) BUX 83,286,229 February 1, 2023 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended […]
Form 7 Monthly Progress Report December 1 2022
Form 7 Monthly Progress Report November 1 2022 Name of Listed Issuer: Trading Symbol: Number of Outstanding Listed Securities: Date: BioMark Diagnostics Inc. (the “Issuer”) BUX 83,286,229 January 4, 2023 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended […]
Form 7 Monthly Progress Report November 1 2022
Form 7 Monthly Progress Report November 1, 2022 Name of Listed Issuer: Trading Symbol: Number of Outstanding Listed Securities: Date: BioMark Diagnostics Inc. (the “Issuer”) BUX 83,286,229 December 6, 2022 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended […]
Form 7 Monthly Progress Report October 1 2022
Form 7 Monthly Progress Report November 1, 2022 Name of Listed Issuer: Trading Symbol: Number of Outstanding Listed Securities: Date: BioMark Diagnostics Inc. (the “Issuer”) BUX 83,286,229 November 1, 2022 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended […]
Form 7 Monthly Progress Report – September 2022
Form 7 Monthly Progress Report – August 2022 Name of Listed Issuer: Trading Symbol: Number of Outstanding Listed Securities: Date: BioMark Diagnostics Inc. (the “Issuer”) BUX 83,286,229 October 2, 2022 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended […]
Form 7 Monthly Progress Report – August 2022
Form 7 Monthly Progress Report – August 2022 Name of Listed Issuer: Trading Symbol: Number of Outstanding Listed Securities: Date: BioMark Diagnostics Inc. (the “Issuer”) BUX 83,286,229 September 1, 2022 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended […]
Form 7 Monthly Progress Report – June 2022
Form 7 – Monthly CSE Progress Report June 2022 Name of Listed Issuer: Trading Symbol: Number of Outstanding Listed Securities: Date: BioMark Diagnostics Inc. (the “Issuer”) BUX 83,286,229 July 4th, 2022 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not […]
Form 7 – Monthly CSE Progress Report May 2022
Form 7 – Monthly CSE Progress Report June 2022 Name of Listed Issuer: Trading Symbol: Number of Outstanding Listed Securities: Date: BioMark Diagnostics Inc. (the “Issuer”) BUX 83,036,228 June 2nd, 2022 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not […]
Liquid Biopsy – What Is It?
A liquid biopsy is a test that is performed on a sample of blood taken from a patient. The test analyzes the blood sample and looks for traces of cancer DNA from tumor cells that are often present in the blood. Multiple blood samples over a period of time allow physicians and doctors to examine […]
10 Reasons why Biomark BUX is a Buy and Long-term Hold
The article presented on this page may contain forward-looking statements. These statements relate to future events or future financial performance. Any statements that are not statements of historical fact (including without limitation statements to the effect that the Company or its management “believes”, “expects”, “anticipates”, “plans”, and similar statements) should be considered forward looking statements. […]
